ANCA-associated vasculitides: advances in pathophysiology and treatment

L P Erwig, C O S Savage

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Substantial progress has been made over the last two decades in our understanding of the immunopathogenesis of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitides. Compelling evidence from in vitro studies and experimental models in conjunction with clinical trials has confirmed that ANCA directly contribute to the evolution and progression of the disease process. Continuous development in our understanding of the mechanisms that drive the disease may ultimately allow us to tailor the multitude of novel therapies, which are rapidly becoming available, to the requirements of individual patients. In this review we endeavour to provide a brief overview of the recent advances in ANCA-associated vasculitides and outline basic principles for diagnosis and treatment of these complex multisystem diseases.
Original languageEnglish
Pages (from-to)62-67
Number of pages6
JournalNetherlands Journal of Medicine
Volume68
Issue number2
Publication statusPublished - Feb 2010

Fingerprint

Antineutrophil Cytoplasmic Antibodies
Vasculitis
Disease Progression
Theoretical Models
Therapeutics
Clinical Trials

Keywords

  • ANCA
  • vasculitis
  • autoimmune disease
  • Wegeners granulomatosis
  • microscopic polyangitis
  • Churg Strauss vasculitis

Cite this

ANCA-associated vasculitides : advances in pathophysiology and treatment. / Erwig, L P; Savage, C O S.

In: Netherlands Journal of Medicine, Vol. 68, No. 2, 02.2010, p. 62-67.

Research output: Contribution to journalArticle

Erwig, L P ; Savage, C O S. / ANCA-associated vasculitides : advances in pathophysiology and treatment. In: Netherlands Journal of Medicine. 2010 ; Vol. 68, No. 2. pp. 62-67.
@article{bcb085a004e14209aadfe865cf8c0329,
title = "ANCA-associated vasculitides: advances in pathophysiology and treatment",
abstract = "Substantial progress has been made over the last two decades in our understanding of the immunopathogenesis of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitides. Compelling evidence from in vitro studies and experimental models in conjunction with clinical trials has confirmed that ANCA directly contribute to the evolution and progression of the disease process. Continuous development in our understanding of the mechanisms that drive the disease may ultimately allow us to tailor the multitude of novel therapies, which are rapidly becoming available, to the requirements of individual patients. In this review we endeavour to provide a brief overview of the recent advances in ANCA-associated vasculitides and outline basic principles for diagnosis and treatment of these complex multisystem diseases.",
keywords = "ANCA, vasculitis, autoimmune disease, Wegeners granulomatosis, microscopic polyangitis, Churg Strauss vasculitis",
author = "Erwig, {L P} and Savage, {C O S}",
year = "2010",
month = "2",
language = "English",
volume = "68",
pages = "62--67",
journal = "Netherlands Journal of Medicine",
issn = "0300-2977",
publisher = "Van Zuiden Communications BV",
number = "2",

}

TY - JOUR

T1 - ANCA-associated vasculitides

T2 - advances in pathophysiology and treatment

AU - Erwig, L P

AU - Savage, C O S

PY - 2010/2

Y1 - 2010/2

N2 - Substantial progress has been made over the last two decades in our understanding of the immunopathogenesis of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitides. Compelling evidence from in vitro studies and experimental models in conjunction with clinical trials has confirmed that ANCA directly contribute to the evolution and progression of the disease process. Continuous development in our understanding of the mechanisms that drive the disease may ultimately allow us to tailor the multitude of novel therapies, which are rapidly becoming available, to the requirements of individual patients. In this review we endeavour to provide a brief overview of the recent advances in ANCA-associated vasculitides and outline basic principles for diagnosis and treatment of these complex multisystem diseases.

AB - Substantial progress has been made over the last two decades in our understanding of the immunopathogenesis of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitides. Compelling evidence from in vitro studies and experimental models in conjunction with clinical trials has confirmed that ANCA directly contribute to the evolution and progression of the disease process. Continuous development in our understanding of the mechanisms that drive the disease may ultimately allow us to tailor the multitude of novel therapies, which are rapidly becoming available, to the requirements of individual patients. In this review we endeavour to provide a brief overview of the recent advances in ANCA-associated vasculitides and outline basic principles for diagnosis and treatment of these complex multisystem diseases.

KW - ANCA

KW - vasculitis

KW - autoimmune disease

KW - Wegeners granulomatosis

KW - microscopic polyangitis

KW - Churg Strauss vasculitis

M3 - Article

C2 - 20167957

VL - 68

SP - 62

EP - 67

JO - Netherlands Journal of Medicine

JF - Netherlands Journal of Medicine

SN - 0300-2977

IS - 2

ER -